Implementation of a mandatory donor RHD screening in Switzerland

Crottet, Sofia Lejon; Henny, Christine; Meyer, Stefan; Still, Franziska; Stolz, Martin; Gottschalk, Jochen; Neuenschwander, Kathrin; Mansouri Taleghani, Behrouz; Gowland, Peter; Frey, Beat M; Fontana, Stefano; Hustinx, Hein; Niederhauser, Christoph; Gassner, Christoph (2014). Implementation of a mandatory donor RHD screening in Switzerland. Transfusion and apheresis science, 50(2), pp. 169-174. Elsevier 10.1016/j.transci.2014.02.011

Text BM_2014_1-s2 0-S1473050214000512-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (233kB)

Starting in 2013, blood donors must be tested at least using: (1) one monoclonal anti-D and one anti-CDE (alternatively full RhCcEe phenotyping), and (2) all RhD negative donors must be tested for RHD exons 5 and 10 plus one further exonic, or intronic RHD specificity, according to the guidelines of the Blood Transfusion Service of the Swiss Red Cross (BTS SRC). In 2012 an adequate stock of RHD screened donors was built. Of all 25,370 RhD negative Swiss donors tested in 2012, 20,015 tested at BTS Berne and 5355 at BTS Zürich, showed 120 (0.47%) RHD positivity. Thirty-seven (0.15%) had to be redefined as RhD positive. Routine molecular RHD screening is reliable, rapid and cost-effective and provides safer RBC units in Switzerland.

Interest & Impact

Downloads

2 since deposited on 26 Mar 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item